Is dapsone FDA approved? Topical yes, oral use differs

Last updated 2026-07-27

Is dapsone FDA approved for acne?

Yes. Topical dapsone gel is FDA approved for acne vulgaris. The 5% formulation (brand name Aczone) got FDA approval in 2005, and a 7.5% once-daily gel version was approved in 2016 ^[1]. Both are approved for patients 12 years and older with acne vulgaris. This is the version almost everyone means when they search for "dapsone for acne." It's a topical gel you rub on your face, not a pill you swallow. The FDA label for Aczone 7.5% states it is indicated "for the topical treatment of acne vulgaris in patients 12 years of age and older" ^[1]. The approval came after multiple randomized, vehicle-controlled trials. The original 5% gel studies (two 12-week trials, over 3,000 patients combined) showed statistically significant reductions in inflammatory and noninflammatory lesions compared to the gel vehicle alone ^[1]. That's a real, FDA-reviewed evidence base, not a wellness-industry claim. Worth saying plainly: oral dapsone tablets are FDA approved too, just not for acne. That distinction is the whole point of this article, and confusing the two products is where people get into trouble.

What exactly is oral dapsone approved to treat?

Oral dapsone (dapsone tablets, USP) is FDA approved for two things: leprosy (Hansen's disease) and dermatitis herpetiformis, a rare autoimmune skin condition linked to celiac disease ^[2]. It is not approved for acne, and no acne indication for the oral tablet exists in its FDA label. Doctors do sometimes prescribe oral dapsone off-label for other conditions (certain vasculitis, some blistering skin diseases, occasionally severe cystic acne resistant to everything else). Off-label prescribing is legal in the US and happens across dermatology, but off-label does not mean FDA-reviewed for that use, and it does not mean the risk profile changes in your favor. The oral drug is a sulfone antibiotic. It works systemically, through your bloodstream. That's exactly why its side effect list is longer and scarier than the topical version's.

What's the real difference between topical and oral dapsone risk?

The difference comes down to how much drug reaches your bloodstream. Topical dapsone gel has minimal systemic absorption. Oral dapsone is absorbed almost completely and circulates through your whole body, which is what creates its risk profile. | Feature | Topical dapsone (Aczone) | Oral dapsone (tablets) |

Why does oral dapsone require G6PD testing?

Because dapsone's breakdown products oxidize red blood cells, and people with glucose-6-phosphate dehydrogenase (G6PD) deficiency can't neutralize that oxidative stress well. The result can be dose-dependent hemolytic anemia, sometimes severe enough to need transfusion or hospitalization ^{[4] [5]}. G6PD deficiency is an X-linked genetic condition affecting an estimated 400 million people worldwide, according to the CDC, with higher prevalence in people of African, Mediterranean, Middle Eastern, and Southeast Asian ancestry ^[5]. Many people with G6PD deficiency have no idea they have it until a drug like dapsone, or certain antimalarials, triggers a hemolytic episode. Clinical guidance and drug references recommend checking G6PD status before starting oral dapsone, precisely because hemolysis risk is dose-related and predictable in deficient patients ^[4]. This is a blood test your prescriber can order before you take your first oral dose. Skipping it isn't a minor shortcut; it's the difference between a manageable treatment and an emergency room visit. Methemoglobinemia is a separate but related risk: dapsone can push more of your hemoglobin into a form (methemoglobin) that can't carry oxygen properly. Everyone on oral dapsone has some degree of this: it's usually mild, but it can become dangerous, especially at higher doses or in people with underlying lung or heart disease ^[2]. If you're researching what Dapsone Rx contraindications actually look like in a clinical intake, G6PD status and baseline blood counts are typically at the top of the list.

Is Aczone (topical dapsone) safe? What does its FDA label actually warn about?

Aczone's FDA label is far shorter on serious warnings than oral dapsone's. The most common adverse reactions reported in trials were application-site dryness, redness, and mild oiliness, occurring in a minority of patients versus vehicle gel ^[1]. One quirk specific to the topical product: using Aczone alongside benzoyl peroxide can cause temporary yellow or orange skin discoloration, which resolves with washing but surprises people who weren't warned about it. That's cosmetic, not dangerous, but it's worth knowing before you layer products. The label does still include a note that G6PD deficiency and hemolysis have been reported rarely with topical use, largely tied to case reports rather than trial data, since absorption is low but not literally zero ^{[1] [3]}. If you already know you're G6PD deficient, mention it to your prescriber regardless of which form you're using. It's a five-minute conversation that removes any doubt. For most people without G6PD deficiency, topical dapsone gel is considered a low-risk, evidence-backed acne treatment, which is why it remains a standard second or third-line option in dermatology alongside topical retinoids and benzoyl peroxide.

Does dapsone actually work for acne? What's the evidence?

The key trials behind Aczone's approval showed a real but moderate effect. In the original 12-week, vehicle-controlled trials supporting the 5% gel, patients using dapsone gel saw statistically greater reductions in inflammatory lesions than those using vehicle gel alone, though the absolute difference was modest compared to some oral or combination therapies ^[1]. Dapsone gel tends to work best for mild-to-moderate inflammatory acne, particularly in adult women, a population where several trials and post-marketing studies found favorable response. It's not typically the first drug a dermatologist reaches for; topical retinoids and benzoyl peroxide usually come first, with dapsone gel added for people who don't tolerate those or need an extra agent. If you want the fuller evidence rundown, including how dapsone gel compares to retinoids and benzoyl peroxide head-to-head, that's covered separately: see what does Dapsone Rx actually do for the mechanism and trial detail. Nobody claims topical dapsone clears severe cystic acne on its own. It's an adjunct, not a magic bullet, and providers usually pair it with something else.

Is it legal to buy dapsone in the US, and do you need a prescription?

Both topical Aczone and oral dapsone tablets are prescription-only in the United States. Neither is available over the counter, and there's no FDA-approved dapsone product you can legally buy without a valid prescription from a licensed provider ^{[1] [2]}. That means any site selling dapsone gel or tablets without requiring a prescription or provider consultation is operating outside the legal, regulated system, and you have no guarantee of what's actually in the product. Compounded topical dapsone also exists in some clinics, made by licensed compounding pharmacies under a prescription, which is a different regulatory pathway than an FDA-approved branded or generic product. If sourcing and legality is what you're actually trying to sort out, Dapsone Rx legal status walks through prescription requirements and where compounded product fits. The provider-reviewed route (a licensed prescriber evaluates your skin, your history, and orders the product through a licensed pharmacy) is the only path that keeps both the legal and safety pieces intact. Dapsone Rx works within that model: connecting patients with providers who review history before any prescription is written, with fulfillment through a licensed pharmacy partner, not a warehouse shipping unregulated powder.

Is generic dapsone the same as Aczone?

Generic topical dapsone gel, once approved by the FDA as bioequivalent, is held to the same standard as brand-name Aczone. FDA generic approval requires the generic product deliver comparable strength, dosage form, and route of administration, with bioequivalence demonstrated to the reference drug . Generic oral dapsone tablets, used for leprosy and dermatitis herpetiformis, have been available for decades and go through the same generic-approval bar. Price is usually the main reason people ask about generic versus brand; generic tablets are typically far cheaper than any branded formulation, though gel pricing varies more by pharmacy and insurance coverage. Bioequivalent doesn't mean identical inactive ingredients, so if you've had a reaction to a specific formulation's gel base, that's worth flagging to your provider before switching.

What are the warning signs of a serious reaction to oral dapsone?

Watch for unusual tiredness, pale or yellowish skin, dark urine, shortness of breath, blue-gray skin discoloration (a methemoglobinemia sign), fever, rash, or sore throat while on oral dapsone. These can signal hemolytic anemia, methemoglobinemia, or the early stages of dapsone hypersensitivity syndrome, and all warrant an immediate call to your prescriber or an ER visit, not a wait-and-see approach ^{[2] [4]}. Dapsone hypersensitivity syndrome is a rare but severe, sometimes fatal, reaction that typically appears 2 to 6 weeks after starting oral dapsone, presenting with fever, rash, and organ involvement (commonly liver) ^[2]. It's one of the reasons oral dapsone isn't something to start casually or without close follow-up. Agranulocytosis, a dangerous drop in white blood cells, is another labeled risk for oral dapsone, which is why prescribers often order baseline and follow-up blood counts ^[2]. None of this is meant to be alarmist for its own sake. It's the actual label language, and it explains why oral dapsone is reserved for specific diseases with specific monitoring, not handed out for skin concerns that topical options already handle.

How is dapsone dosed differently for topical versus oral use?

Topical Aczone 7.5% gel is applied once daily, a pea-sized amount to the entire affected area of the face (and sometimes trunk, off-label), after cleansing ^[1]. The older 5% gel was applied twice daily. Absorption stays low either way, which is the core reason the systemic risk list is short. Oral dapsone dosing for dermatitis herpetiformis typically starts low (as low as 25 to 50 mg per day) and titrates based on response and tolerability, per the FDA label, with regular monitoring ^[2]. Leprosy dosing follows WHO multidrug therapy regimens, combined with other antibiotics like rifampicin, not dapsone alone . Dosing specifics, half-life, and how long dapsone stays detectable matter more for the oral form, since that's where systemic levels and monitoring intervals actually count. If you want that level of detail, Dapsone Rx half life and Dapsone Rx storage and shelf life cover the pharmacokinetics and practical storage questions separately.

Can you get topical dapsone through Dapsone, and is that legitimate?

Dapsone Rx connects patients researching topical dapsone with licensed providers who review medical history, including G6PD-relevant flags, before writing any prescription, and fulfillment runs through a licensed US pharmacy partner. It doesn't compound or manufacture anything itself. It's a provider-reviewed access point into the FDA-approved (or FDA-approved-generic) products described throughout this article, not a separate product line. That distinction matters because plenty of gray-market sellers online will ship dapsone-labeled products with no medical review and no verifiable pharmacy behind them. A provider-reviewed model exists specifically to keep the prescription requirement, the G6PD conversation, and the pharmacy-grade sourcing intact, rather than skipping straight to checkout. If your actual question is whether a product is legit, purity and testing documentation is the concrete thing to look for; see Dapsone Rx purity and testing for what that documentation should include.

Frequently asked questions

Is dapsone FDA approved for acne?

Yes. Topical dapsone gel (Aczone) is FDA approved for acne vulgaris in patients 12 and older. The 5% gel was approved in 2005 and the 7.5% once-daily gel in 2016, based on multiple vehicle-controlled clinical trials showing reduced inflammatory lesions.

Is oral dapsone FDA approved?

Yes, but for different diseases. Oral dapsone tablets are FDA approved for leprosy (Hansen's disease) and dermatitis herpetiformis, not for acne. Any acne use of the oral tablet would be off-label and carries systemic risks the topical gel doesn't.

Do you need a G6PD test before using dapsone?

For oral dapsone, yes, testing is recommended before starting because G6PD-deficient patients face a much higher risk of drug-induced hemolytic anemia. For topical Aczone, G6PD testing isn't required by the label, though rare cases of hemolysis have been reported with topical use too.

What's the difference between Aczone and dapsone?

Aczone is the brand name for topical dapsone gel, FDA approved for acne. "Dapsone" alone usually refers to the oral tablet form, FDA approved for leprosy and dermatitis herpetiformis. Both use the same drug molecule, but absorption, risk profile, and approved use differ sharply between the two.

Can dapsone gel cause skin discoloration?

Yes, temporary yellow or orange discoloration can occur when Aczone gel is used together with benzoyl peroxide products. It washes off and isn't dangerous, but it surprises people who weren't warned, so dermatologists usually mention it upfront.

Is dapsone a sulfa drug?

Dapsone is a sulfone, chemically related to but distinct from sulfonamide ("sulfa") antibiotics. People with true sulfonamide allergies don't automatically react to dapsone, but cross-reactivity concerns should still be discussed with a prescriber before starting either form.

What is dapsone hypersensitivity syndrome?

It's a rare, potentially severe reaction to oral dapsone involving fever, rash, and organ damage (often the liver), typically appearing 2 to 6 weeks after starting treatment. It's listed as a warning on the oral dapsone FDA label and is a major reason oral use requires close monitoring.

Can you buy dapsone without a prescription?

No. Both topical Aczone and oral dapsone tablets are prescription-only in the US. There's no FDA-approved over-the-counter dapsone product; any site selling it without a prescription requirement is operating outside the regulated system.

Does topical dapsone gel have the same risks as oral dapsone tablets?

No. Topical gel has minimal systemic absorption, so serious risks like hemolytic anemia, methemoglobinemia, and agranulocytosis are rare and mostly tied to oral use. Topical side effects are typically limited to local dryness, redness, or mild irritation.

How long has dapsone been an FDA approved drug?

Oral dapsone has been used medically for decades, predating the modern FDA framework, and remains approved for leprosy and dermatitis herpetiformis. The topical acne formulation is newer: 5% gel approved in 2005, 7.5% gel approved in 2016.

Is generic dapsone as effective as brand-name Aczone?

FDA-approved generic dapsone gel must demonstrate bioequivalence to brand-name Aczone, meaning comparable absorption and effect. Inactive ingredients in the gel base can differ slightly, which occasionally matters for people with sensitive skin, but the drug delivery is held to the same standard.

Why does oral dapsone require blood monitoring?

Oral dapsone can cause hemolytic anemia, methemoglobinemia, and rarely agranulocytosis (a dangerous drop in white blood cells). Prescribers typically order baseline and periodic follow-up blood counts to catch these problems early, since they're dose-related and more likely in G6PD-deficient patients.

Sources

1. FDA label, Aczone (dapsone) gel 7.5%: Aczone 7.5% gel indication, approval details, and adverse reactions
2. MedlinePlus, Dapsone: G6PD testing recommendation before oral dapsone use and hemolysis risk
3. CDC, Glucose-6-Phosphate Dehydrogenase Deficiency: G6PD deficiency prevalence and populations affected
4. FDA, Generic Drugs: Questions and Answers: FDA bioequivalence standard for generic drug approval
5. World Health Organization, Guidelines for the Diagnosis, Treatment and Prevention of Leprosy: Multidrug therapy regimen combining dapsone with rifampicin for leprosy